INTAGLIATA, SEBASTIANO
 Distribuzione geografica
Continente #
NA - Nord America 922
EU - Europa 899
AS - Asia 95
AF - Africa 86
OC - Oceania 2
SA - Sud America 1
Totale 2.005
Nazione #
US - Stati Uniti d'America 900
IT - Italia 501
IE - Irlanda 221
CN - Cina 65
SN - Senegal 47
RU - Federazione Russa 42
DE - Germania 38
UA - Ucraina 29
CI - Costa d'Avorio 28
CA - Canada 22
FR - Francia 18
VN - Vietnam 17
GB - Regno Unito 11
NG - Nigeria 8
CH - Svizzera 6
PL - Polonia 6
ES - Italia 5
GR - Grecia 3
IN - India 3
RO - Romania 3
SE - Svezia 3
SG - Singapore 3
AU - Australia 2
CM - Camerun 2
CZ - Repubblica Ceca 2
FI - Finlandia 2
HK - Hong Kong 2
LU - Lussemburgo 2
NL - Olanda 2
AT - Austria 1
BE - Belgio 1
BG - Bulgaria 1
BY - Bielorussia 1
CL - Cile 1
EG - Egitto 1
HU - Ungheria 1
IQ - Iraq 1
IR - Iran 1
KR - Corea 1
LB - Libano 1
TW - Taiwan 1
Totale 2.005
Città #
Chandler 276
Dublin 217
Catania 112
Houston 66
Cambridge 51
Lawrence 48
Dakar 47
Andover 46
Ashburn 44
Redmond 38
Jacksonville 30
Abidjan 28
Boydton 24
Des Moines 22
Wilmington 22
Nanjing 20
Rome 20
Palermo 19
Bremen 17
Dong Ket 15
Toronto 14
Boardman 11
Milan 10
Beijing 9
Civitavecchia 9
Messina 9
Abuja 8
Hebei 8
Gela 7
Ottawa 7
Saint Petersburg 7
Siracusa 7
Ferrara di Monte Baldo 6
Foggia 6
Moscow 6
Fairfield 5
Nanchang 5
Padova 5
Raffadali 5
Reggio Calabria 5
Shenyang 5
Milazzo 4
Vicenza 4
Washington 4
Bucharest 3
Changsha 3
Ferrara 3
Gunzenhausen 3
Latina 3
Lucca 3
Madrid 3
Mascalucia 3
Modica 3
New Haven 3
Norwalk 3
Novara 3
San Mateo 3
Villamagna 3
Cergy 2
Dallas 2
Esslingen am Neckar 2
Floridia 2
Froges 2
Giardini-Naxos 2
Hanoi 2
Hanover 2
Jiaxing 2
Jinan 2
Kraków 2
Manduria 2
New Orleans 2
Paris 2
Providence 2
Salerno 2
San Francisco 2
Seattle 2
Tianjin 2
Torregrotta 2
Tusa 2
Valencia 2
Woodbridge 2
Wroclaw 2
Aci Castello 1
Aci Catena 1
Acireale 1
Agropoli 1
Alcamo 1
Ann Arbor 1
Ardabil 1
Bronte 1
Brussels 1
Budapest 1
Cairo 1
Calatabiano 1
Cassano D'adda 1
Castelvetrano 1
Central 1
Changchun 1
Cracow 1
Den Haag 1
Totale 1.436
Nome #
Design, synthesis, and pharmacological evaluation of NO donor-sigma receptors hybrids for the treatment of cancer 90
Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent in Vitro Antiproliferative Activity 83
Combination of heme oxygenase-1 inhibition and sigma receptor modulation for anticancer activity 70
[1]Benzothieno[3,2-d]pyrimidine derivatives as ligands for the serotonergic 5-HT7 receptor 64
Synthesis and Molecular Modelling Studies of New 1,3-Diaryl-5-Oxo-Proline Derivatives as Endothelin Receptor Ligands 61
Structure-Activity Relationships and Therapeutic Potentials of 5-HT7 Receptor Ligands: An Update 60
Solid lipid nanoparticles loading idebenone ester with pyroglutamic acid: In vitro antioxidant activity and in vivo topical efficacy 58
Synthesis, in vitro and in vivo characterization of new benzoxazole and benzothiazole-based sigma receptor ligands 58
New arylethanolimidazole derivatives as HO-1 inhibitors with cytotoxicity against MCF-7 breast cancer cells 57
Novel structural insight into inhibitors of heme oxygenase-1 (ho-1) by new imidazole-based compounds: Biochemical and in vitro anticancer activity evaluation 52
Discovery of SI 1/20 and SI 1/22 as Mutual Prodrugs of 5-Fluorouracil and Imidazole-Based Heme Oxygenase 1 Inhibitor with Improved Cytotoxicity in DU145 Prostate Cancer Cells 50
A computer-aided approach to identify novel Leishmania major protein disulfide isomerase inhibitors for treatment of leishmaniasis 49
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines 49
Glucose-impaired Corneal Re-epithelialization Is Promoted by a Novel Derivate of Dimethyl Fumarate 48
Chromatograpic resolution of phenylethanolic-azole racemic compounds highlighted stereoselective inhibition of heme oxygenase-1 by (R)-enantiomers 46
ATTIVITÀ ANTIOSSIDANTE IN VITRO DI DERIVATI DELL’IDEBENONE 45
Examination of the Novel Sigma‐1 Receptor Antagonist, SI 1/28, for Antinociceptive and Anti‐Allodynic Efficacy against Multiple Types of Nociception with Fewer Liabilities of Use 45
Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective 45
Development of New Benzylpiperazine Derivatives as σ1Receptor Ligands with in Vivo Antinociceptive and Anti-Allodynic Effects 43
New N- and O-arylpiperazinylalkyl pyrimidines and 2-methylquinazolines derivatives as 5-HT7 and 5-HT1A receptor ligands: Synthesis, structure-activity relationships, and molecular modeling studies 42
Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors 41
Lipid nanoparticles traverse non-corneal path to reach the posterior eye segment: In vivo evidence 40
Novel Tyrosine Kinase Inhibitors to Target Chronic Myeloid Leukemia 39
Design and synthesis of new homo and hetero bis-piperazinyl-1- propanone derivatives as 5-HT7R selective ligands over 5-HT1AR 37
Mutual Prodrugs of 5-Fluorouracil: From a Classic Chemotherapeutic Agent to Novel Potential Anticancer Drugs 37
Synthesis and in vitro antioxidant activity of a novel idebenone ester with pyroglutamic acid. 37
Protective Effects of Caffeic Acid Phenethyl Ester (CAPE) and Novel Cape Analogue as Inducers of Heme Oxygenase-1 in Streptozotocin-Induced Type 1 Diabetic Rats 37
Ginseng and heme oxygenase-1: The link between an old herb and a new protective system 37
Novel mutual prodrug of 5-fluorouracil and heme oxygenase-1 inhibitor (5-FU/HO-1 hybrid): design and preliminary in vitro evaluation 36
Heme Oxygenase Modulation Drives Ferroptosis in TNBC Cells 35
Synthesis, in vitro and in silico studies of HO-1 inducers and lung antifibrotic agents 35
Exploring 1-adamantanamine as an alternative amine moiety for metabolically labile azepane ring in newly synthesized benzo[d]thiazol-2(3H)one σ receptor ligands 35
The analgesic potential of glycosides derived from medicinal plants 34
Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 33
Structure-activity relationships and molecular modeling studies of novel arylpiperazinylalkyl 2-benzoxazolones and 2-benzothiazolones as 5-HT7 and 5-HT1A receptor ligands 32
Characterization of sigma 1 receptor antagonist CM-304 and its analog, AZ-66: Novel therapeutics against allodynia and induced pain 32
Divergent cytotoxic and metabolically stimulative functions of sigma-2 receptors: Structure-Activity Relationships of 6-Acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79) Derivatives 31
Discovery of a Highly Selective Sigma-2 Receptor Ligand, 1-(4-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-3-methyl-1H-benzo[d]imidazol-2(3H)-one (CM398), with Drug-Like Properties and Antinociceptive Effects In Vivo 30
In vitro antioxidant and anti-glycation activity of resveratrol and its novel triester with trolox 30
New thienopyrimidine and quinazoline derivatives as potential 5-HT7 receptor ligands. 27
Synthesis and binding properties of new long-chain 4-substituted piperazine derivatives as 5-HT1A and 5-HT7 receptor ligands 27
Benzimidazolone-based selective σ2 receptor ligands: Synthesis and pharmacological evaluation 27
Bioanalytical method development and pharmacokinetics of MCI-92, a sigma-1 receptor ligand 26
New homo and hetero bis-arylpiperazine and bis-benzylpiperazine derivatives as 5-HT7R selective ligands: design and synthesis 24
Novel selective ligands for the serotonergic 5-HT7 receptor: tricyclic derivatives Bearing the pyrimido-4(3H)-one ring 23
Strategies to improve resveratrol systemic and topical bioavailability: An update 23
Structure-activity relationships of mixed σ1R/σ2R ligands with antiproliferative and anticancer effects 21
Discovery of 3-(2-aminoethyl)-thiazolidine-2,4-diones as a novel chemotype of sigma-1 receptor ligands 20
Laboratory-Scale Semipreparative Enantioresolution of Phenylethanolic-Azole Heme Oxygenase-1 Inhibitors 19
New 5-Ht7 Receptor Ligands As Potential Antidepressant Agents. 18
New alkylpiperazines as 5-HT7R ligands 17
Thieno[3,2-d]pyrimidine as a scaffold for 5-HT7 receptor ligands 16
Characterization of CM-398, a Novel Selective Sigma-2 Receptor Ligand, as a Potential Therapeutic for Neuropathic Pain 14
UPLC-MS/MS method for the quantification of MCI-77, a novel sigma-1 receptor ligand, and its application to pharmacokinetic studies 14
In vitro and in silico analysis of imatinib analogues as anti- Trypanosoma cruzi drug candidates 11
Novel benzothiazolones and benzoxazolones-based σ receptor ligands: synthesis and preliminary pharmacological evaluation against allodynia 10
The Inhibition of Neuropathic Pain Incited by Nerve Injury and Accompanying Mood Disorders by New Heme Oxygenase-1 Inducers: Mechanisms Implicated 4
Totale 2.124
Categoria #
all - tutte 6.149
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.149


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201943 0 0 0 0 0 12 16 5 2 1 1 6
2019/2020246 47 28 22 9 26 10 22 2 8 39 14 19
2020/2021204 6 9 41 12 54 6 14 4 6 10 23 19
2021/2022507 36 57 59 16 67 17 69 33 17 27 11 98
2022/2023902 69 74 38 116 67 126 3 156 171 15 52 15
2023/2024188 20 52 21 22 55 18 0 0 0 0 0 0
Totale 2.124